HealthMedical
World's First Hepatitis B Functional Cure mRNA Drug in China
Chinese researchers in Nanjing developed CPU-YL01, the world's first mRNA drug targeting a functional cure for Hepatitis B, now in Phase I trials.
—6 min read
Tag
3 articles
Chinese researchers in Nanjing developed CPU-YL01, the world's first mRNA drug targeting a functional cure for Hepatitis B, now in Phase I trials.
Chinese researchers identified SCARF2, a 'navigator' protein guiding Hepatitis B virus to the cell nucleus, opening new pathways for curative treatments.
Phase III trials show bepirovirsen achieves functional cure in 19% of chronic hepatitis B patients, marking a major treatment advance.